BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 25, 2025
See today's BioWorld
Home
» Other news to note for May 4, 2021
To read the full article
sign up for free
or
sign in
.
Other news to note for May 4, 2021
May 4, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcellera, Abpro, Alligator, Aphios, APR, Aria, Astrazeneca, Aura, Bioarctic, Biocartis, Cartesian, CSL, Edgewise, Effector, Enesi, Esteve, Evotec, Exelixis, Gain, Gamamabs, Gemini, Gensight, Hcmed, Hoth, Hutchmed, Immunicum, J&J, Kowa, Lilly, Logicbio, Moderna, Moonlake, Merck KGaA, Nflection, Novobiome, Ocugen, Plus, Proqr, Recce, Relief, Samsung Bioepis, Sesen, Stoke, Twoxar, Xoma, Yarrow.
BioWorld
Briefs
Other news to note
Coronavirus